Taiho Oncology, Inc.
Olof Harlin has extensive work experience in the medical industry. Olof currently holds the position of Senior Director Medical Affairs at Taiho Oncology, Inc. since July 2022. Prior to this, they worked as a Medical Consultant in the biotechnology industry at Olof Harlin Medical Consultancy starting in September 2018.
From June 2021 to July 2022, Olof Harlin served as the Senior Director and Global Medical Affairs Leader at Oncopeptides AB. Before that, they held the roles of Global Medical Affairs Director from March 2020 to May 2021, and Head of Medical Affairs Europe from November 2018 to March 2021 at Oncopeptides AB.
Olof also worked as the Medical Lead DACH at Prothena Corporation plc from August 2017 to August 2018. Prior to that, they were a Global Medical Manager specializing in Oncology at Sandoz from September 2016 to August 2017.
Before joining Sandoz, Olof Harlin worked at Biogen as a Senior Medical Manager from January 2014 to August 2016. From January 2012 to December 2013, they held the position of Head of MSLs at Vifor Pharma, and from June 2010 to December 2011, they worked as a Medical Manager at Vifor Pharma.
Olof started their career as a Freelance Medical Advisor/Manager from October 2009 to June 2010 and then joined Novartis as a Medical Advisor from February 2009 to July 2009. Olof Harlin's early experience in the industry includes working as an International Publication Manager at Roche Pharmaceuticals from September 2008 to January 2009.
Overall, Olof Harlin has a diverse background in medical affairs, medical consultancy, and management roles within pharmaceutical companies, showcasing their expertise in various areas of the medical industry.
Olof Harlin pursued their education at Ludwig-Maximilians-Universität München. Olof completed their Doctor of Veterinary Medicine (DVM) degree from 1994 to 2000, specializing in Veterinary Medicine. Following this, they continued their studies at the same university and obtained a PhD in Immunology and Oncology from 2000 to 2003. Additionally, they have some background in Chemistry, having studied at Uppsala University, although the specific years and degree attained are unknown.
This person is not in any offices
Taiho Oncology, Inc.
2 followers
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development of orally administered anti-cancer agents and markets these medicines for a range of tumor types in the U.S. Taiho Oncology’s growing pipeline of selectively targeted anti-cancer agents is led by a world-class clinical development organization. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. For more information, visit www.taihooncology.com